Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2) - Image 1

£74.54

Elsevier Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)

Name: Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)
Brand: Elsevier
Price: 74.54 GBP
Availability: InStock

Infectious & Contagious Diseases

This is the most expensive it has ever been. Walk away.

£75 today · previous high £75 · all-time low £74

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 80 days · 80 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 80 days • 1 price levels

Days at Price

Price Analysis

Most common price: £75 (80 days, 100.0%)

Price range: £75 - £75

Price levels: 1 different prices over 80 days

Description

For many years, physicians and the public assumed that the discovery of new antimicrobial agents would outpace the ability of bacteria to mutate and develop drug resistance. Yet the development of new antibiotics has not kept up with bacterial evolution, especially since the late 1990's. At that time a multitude of pharmaceutical companies abandoned antibiotic research because of strong economic disincentives. For example, it is challenging for these companies to recuperate the investment (typically in the hundreds of millions of dollars) made in developing a new antibiotic, which is typically prescribed for a few days, compared to drugs that treat chronic conditions like heart disease or mental illness. This situation has led the U.S. federal government to take a more active lead in addressing antibiotic resistance. Recently, the White House announced an action plan that includes improving surveillance, developing better diagnostic tools, accelerating drug development, and improving global coordination of antibiotic resistance issues. Equally important is the $1.2 billion dollars that has been pledged to fund these efforts. While we await the implementation of new policies, this issue of Infectious Disease Clinics of North America brings together leading authorities in the field of antibiotic resistance who discuss current issues including antibiotic stewardship, the changing role of the microbiology laboratory in determining antibiotic resistance in gram-negative pathogens, the continuing spread of metallo-?-lactamases, ESBLs and KPCs, antibiotic options for treating resistant gram-negative infections such as colistin and tigecycline, resistance mechanisms and new treatment options for Mycobacterium tuberculosis, emerging resistance mechanisms in aminoglycosides, issues with antibiotic resistance in immunocompromised patients, new ?-lactamase inhibitors in the clinic, and resistance in VRE and Staphylococcus aureus. Additionally, combination therapy for resistant gram-negative infections has been advocated by some authorities and the advantages and disadvantages of this strategy will be reviewed.

Product Specifications

Brand: Elsevier
Format: hardcover
ASIN: 0323446183
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Infectious & Contagious Diseases
Domain: Amazon UK
Release Date: 28 June 2016
Listed Since: 25 November 2015

Barcode

No barcode data available

Elsevier Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Ongoing Challenge of Antimicrobial Resistance, An Issue of Infectious Disease Clinics of North America: Volume 34-4 (The Clinics: Internal Medicine, Volume 34-4)

Antibiotics and Antibiotic Resistance in the Environment

Antimicrobial Resistance and Implications for the 21st Century (Emerging Infectious Diseases of the 21st Century)

National Strategy & Action Plan for Combating Antibiotic Resistant Bacteria

Antibiotic Resistance: 211 (Handbook of Experimental Pharmacology, 211)

Antibiotics: Methods and Protocols: 1520 (Methods in Molecular Biology, 1520)

Antimicrobial Resistance: Collaborative Measures of Control

Antibiotic Resistance Protocols: Second Edition: 642 (Methods in Molecular Biology)

21st Century Challenges in Antimicrobial Therapy and Stewardship (Frontiers in Anti-Infective Agents)

Springer - Antimicrobials: New and Old Molecules Book

Antimicrobial Resistance in the Environment

Antibiotic Resistance: Mechanisms and New Antimicrobial Approaches

Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary

The Global Antimicrobial Resistance Epidemic - Innovative Approaches and Cutting-Edge Solutions

The Chemistry and Biology of Beta-Lactams

Antibiotic Resistance: Origins, Evolution, Selection and Spread: No.207 (Novartis Foundation Symposia)

Antibiotic Materials in Healthcare

Ashgate Handbook of Anti-Infective Agents: An International Guide to 1, 600 Drugs in Current Use: An International Guide to 1, 600 Drugs in Current Use (Routledge Revivals)

Antibiotic Essentials 2024

Antimicrobial Resistance: Global Challenges and Future Interventions

Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine, 3)